Sujata Prasad
Internal Medicine · Oklahoma City, OKNPI 1598740235
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $874 and has fallen 96.0% since, to $35 in 2025.
Across 177 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$438
- Boehringer Ingelheim$333
- AstraZeneca$324
- GSK$313
- Amgen$257
- Novartis$157
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,863100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $438 |
| Boehringer Ingelheim | 20 | $333 |
| AstraZeneca | 21 | $324 |
| GSK | 15 | $313 |
| Amgen | 17 | $257 |
| Novartis | 10 | $157 |
| Lilly USA, LLC | 10 | $153 |
| Novo Nordisk | 9 | $136 |
| Johnson & Johnson | 5 | $95 |
| Sunovion Pharmaceuticals Inc. | 6 | $76 |
| Mylan Specialty L.p. | 3 | $65 |
| Dexcom, Inc. | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $45 |
| Sanofi-aventis U.S. LLC | 3 | $41 |
| Merck | 3 | $40 |
| Pfizer | 2 | $36 |
| Abbott | 2 | $33 |
| Inogen, Inc. | 2 | $31 |
| Eisai Inc. | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Philips North America LLC | 1 | $19 |
| Advanced Respiratory, Inc | 1 | $19 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $14 |
| Bardy Diagnostics, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Medtronic | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$2,869 in reported general payments places this provider in the 80th percentile of 840 internal medicine providers in Oklahoma.
Other internal medicine in Oklahoma City
- Ryan MorganOklahoma City$235K
- Ali JafryOklahoma City$33K
- Samid FarooquiOklahoma City$20K
- Dale BratzlerOklahoma City$17K
- Karen ChopraOklahoma City$16K
- Charlsie RecordOklahoma City$14K
- Jeannette KelleyOklahoma City$14K
- Zain Ul Abideen AsadOklahoma City$14K
- Stuart SchraderOklahoma City$12K
- Patrick GarrisonOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.